Update from the National Hypertension Taskforce of Australia: prevalence, treatment and control rates of hypertension between 2022 and 2024 — implications and future directions
Amelie H Ohlrogge, Xiaoyue Xu, Andrew Goodman, Garry Jennings, Lisa Murphy, Mark R Nelson, James E Sharman, Rob Tassie, Markus P Schlaich, Aletta E Schutte · 2026
Read Update from the National Hypertension Taskforce of Australia: prevalence, treatment and control rates of hypertension between 2022 and 2024 — implications and future directions by Amelie H Ohlrogge, Xiaoyue Xu, Andrew Goodman, Garry Jennings, Lisa Murphy, Mark R Nelson, James E Sharman, Rob Tassie, Markus P Schlaich, Aletta E Schutte (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13336605.txt.
Description
Amelie H Ohlrogge and colleagues published a 2026 update on high blood pressure across Australia. Drawing on the National Health Survey, the update tracks how common the condition is, how often it is treated, and how often it is brought under control between 2022 and 2024. High blood pressure remains the leading risk factor for heart disease and early death in the country.
Control improved to 39.6 percent in 2022 to 2023, up from 32 percent in 2017 to 2018, while overall prevalence rose from 33.7 to 39.4 percent. Rates were worse for First Nations peoples, younger people, and people in poorer areas. The authors argue that fairer care is essential if Australia is to reach its goal of 70 percent control by 2030.
Catalog record
| CREATOR | Amelie H Ohlrogge, Xiaoyue Xu, Andrew Goodman, Garry Jennings, Lisa Murphy, Mark R Nelson, James E Sharman, Rob Tassie, Markus P Schlaich, Aletta E Schutte |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |